Preclinical evaluation of immunogenicity and protective efficacy of a recombinant chimeric protein vaccine against visceral leishmaniasis.
Lage DP, Vale DL, Maia FAG, Martins VT, Silva MGP, Galvani NC, Cardoso MM, Moreira GJL, Sombrio EM, Freitas CS, Pimenta BL, Falcão KOM, Dias SSG, Bandeira RS, Pereira IAG, Tavares GSV, Teixeira AL, Chávez-Fumagalli MA, Roatt BM, Machado-de-Ávila RA, Coelho EAF.
Lage DP, et al. Among authors: teixeira al.
Parasitology. 2024 Nov 28:1-13. doi: 10.1017/S0031182024001240. Online ahead of print.
Parasitology. 2024.
PMID: 39604215